These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11993250)

  • 1. New applications of contemporary biomarkers of alcohol consumption.
    Bean P; De Bruin T; Harasymiw J; Hallinan P
    Am Clin Lab; 2002 Mar; 21(2):19-21. PubMed ID: 11993250
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of contemporary biomarkers in the detection of chronic alcohol use.
    Montalto NJ; Bean P
    Med Sci Monit; 2003 Dec; 9(12):RA285-90. PubMed ID: 14646983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrin.
    Merikallio-Pajunen A; Strid N; Suokas A; Podlketnova I; Alho H
    Addict Behav; 2004 Jun; 29(4):717-22. PubMed ID: 15135553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic tests of alcohol consumption].
    Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2002 Aug; 13(74):154-7. PubMed ID: 12420351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting alcohol abuse: the value of carbohydrate deficient transferrin.
    Stout RL
    J Insur Med; 1998; 30(2):123-4. PubMed ID: 10339297
    [No Abstract]   [Full Text] [Related]  

  • 8. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbohydrate-deficient transferrin as the marker of alcohol abuse].
    Fehér J; Lengyel G; Szabó G
    Orv Hetil; 2006 Oct; 147(40):1915-20. PubMed ID: 17111682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic markers of alcohol abuse].
    Zima T
    Vnitr Lek; 2003 Feb; 49(2):92. PubMed ID: 12728572
    [No Abstract]   [Full Text] [Related]  

  • 11. [B-PEth and other markers of excessive alcohol us. A comparative study in general practice].
    Bjerre B
    Lakartidningen; 2009 Apr 7-21; 106(15-16):1099-100, 1102-3. PubMed ID: 19492677
    [No Abstract]   [Full Text] [Related]  

  • 12. Unhealthy alcohol use.
    Schwan R; Allen JP
    N Engl J Med; 2005 May; 352(20):2139-40; author reply 2139-40. PubMed ID: 15901874
    [No Abstract]   [Full Text] [Related]  

  • 13. How has screening of harmful drinking changed over the years?
    Vincenti M; Salomone A; Pirro V
    Bioanalysis; 2013 Dec; 5(24):2981-3. PubMed ID: 24320123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comments on the article by Dastych M. et al: "Diagnostic value of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean erythrocyte volume as laboratory markers of chronic alcohol abuse"].
    Fingerová H
    Vnitr Lek; 2003 Feb; 49(2):92-4. PubMed ID: 12728573
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical alcohol screening in primary health care.
    Miller PM; Anton RF
    Addict Behav; 2004 Sep; 29(7):1427-37. PubMed ID: 15345274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CDT: a biological marker of alcohol abuse].
    Crespi V; Andreotta U; Tettamanzi E; Ferrario MM
    Med Lav; 2007; 98(6):466-74. PubMed ID: 18041466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New biomarkers for assesing alcohol consumption].
    Aakerøy R; Skråstad RB; Helland A; Hilberg T; Aamo T; Dyrkorn R; Spigset O
    Tidsskr Nor Laegeforen; 2016 Oct; 136(19):1643-1647. PubMed ID: 27790892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005.
    Bortolotti F; De Paoli G; Tagliaro F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Sep; 841(1-2):96-109. PubMed ID: 16725384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A useful test for monitoring alcohol use.
    Miller PM; Cluver J; Anton RF
    Behav Healthc; 2009 Jun; 29(6):38, 40. PubMed ID: 19655583
    [No Abstract]   [Full Text] [Related]  

  • 20. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
    Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.